| 2021 |
Raborn LN, Pan KS, FitzGibbon EJ, Collins MT, Boyce AM. Optic disc edema in fibrous dysplasia/McCune-Albright syndrome: prevalence, etiologies, and clinical implications. Bone. February 2021;143:115661. |
0 |
0 |
| 2021 |
Gladding A, Szymczuk V, Auble BA, Boyce AM. Burosumab treatment for fibrous dysplasia. Bone. September 2021;150:116004. |
0 |
0 |
| 2022 |
Hopkins C, de Castro LF, Corsi A, Boyce A, Collins MT, Riminucci M, Heegaard A-M. Fibrous dysplasia animal models: a systematic review. Bone. February 2022;155:116270. |
0 |
0 |
| 2020 |
Pan KS, de Castro LF, Roszko KL, Greenberg ED, FitzGibbon EJ, Dufresne CR, Boyce AM, Collins MT. Successful intravascular treatment of an intraosseous arteriovenous fistula in fibrous dysplasia. Calcif Tiss Int. August 2020;107(2):195-200. |
0 |
0 |
| 2020 |
Pan KS, FitzGibbon EJ, Vitale S, Lee JS, Collins MT, Boyce AM. Utility of optical coherence tomography in the diagnosis and management of optic neuropathy in patients with fibrous dysplasia. J Bone Miner Res. November 2020;35(11):2199-2210. |
0 |
0 |
| 2022 |
Geels RES, Meier ME, Saikali A, Tsonaka R, Appelman-Dijkstra NM, Boyce AM. Long bone fractures in fibrous dysplasia/McCune-Albright syndrome: prevalence, natural history, and risk factors. J Bone Miner Res. February 2022;37(2):236-243. |
3 |
0 |
| 2022 |
Gafni RI, Langman CB, Guthrie LC, Brillante BA, James R, Yovetich NA, Boyce AM, Collins MT. Hypocitraturia is an untoward side effect of synthetic human parathyroid hormone (hPTH) 1–34 therapy in hypoparathyroidism that may increase renal morbidity. J Bone Miner Res. April 2022;37(4):818. |
0 |
0 |
| 2022 |
Szymczuk V, Taylor J, Michel Z, Sinaii N, Boyce AM. Skeletal disease acquisition in fibrous dysplasia: natural history and indicators of lesion progression in children. J Bone Miner Res. August 2022;37(8):1473-1478. |
3 |
1 |
| 2022 |
Hartley IR, Gafni RI, Roszko KL, Brown SM, de Castro LF, Saikali A, Ferreira CR, Gahl WA, Pacak K, Blau JE, Boyce AM, Salusky IB, Collins MT, Florenzano P. Determination of FGF23 levels for the diagnosis of FGF23-mediated hypophosphatemia. J Bone Miner Res. November 2022;37(11):2174-2185. |
0 |
0 |
| 2023 |
Roszko KL, Guthrie L, Li X, Collins MT, de Castro LF, Boyce AM. Identification of GNAS variants in circulating cell-free DNA from patients with fibrous dysplasia/McCune Albright syndrome. J Bone Miner Res. March 2023;38(3):443-450. |
0 |
0 |
| 2023 |
Meier ME, Appelman-Dijkstra NM, Collins MT, Geels RES, Stanton RP, de Witte PB, Boyce AM, van de Sande MAJ. Coxa vara deformity in fibrous dysplasia/McCune-Albright syndrome: prevalence, natural history and risk factors: a two-center study. J Bone Miner Res. July 2023;38(7):968-975. |
0 |
0 |
| 2023 |
Pan KS, Taylor J, Szymczuk V, Boyce AM. Lesion expansion in gnathic fibrous dysplasia: natural history, indicators of progression, and response to bisphosphonates. J Bone Miner Res. October 2023;38(10):1465-1471. |
0 |
0 |